Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Exponent stock | $91.23
Learn how to easily invest in Exponent stock.
Exponent, Inc is a consulting services business based in the US. Exponent shares (EXPO) are listed on the NASDAQ and all prices are listed in US Dollars. Exponent employs 906 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Exponent
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EXPO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Exponent stock price (NASDAQ: EXPO)Use our graph to track the performance of EXPO stocks over time.
Exponent shares at a glance
|Latest market close||$91.23|
|52-week range||$67.97 - $102.19|
|50-day moving average||$90.64|
|200-day moving average||$93.57|
|Wall St. target price||$111.00|
|Dividend yield||$0.77 (0.78%)|
|Earnings per share (TTM)||$1.64|
Buy Exponent shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Exponent stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Exponent price performance over time
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||0.51%|
|3 months (2021-04-30)||-5.29%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Is Exponent under- or over-valued?
Valuing Exponent stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Exponent's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Exponent's P/E ratio
Exponent's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Exponent shares trade at around 61x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Exponent's PEG ratio
Exponent's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.14. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Exponent's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Exponent's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $78.1 million.
The EBITDA is a measure of a Exponent's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$388.3 million|
|Operating margin TTM||18.37%|
|Gross profit TTM||$128.4 million|
|Return on assets TTM||8.41%|
|Return on equity TTM||24.85%|
|Market capitalisation||$5.2 billion|
TTM: trailing 12 months
Shorting Exponent shares
There are currently 1.0 million Exponent shares held short by investors – that's known as Exponent's "short interest". This figure is 5.8% up from 977,475 last month.
There are a few different ways that this level of interest in shorting Exponent shares can be evaluated.
Exponent's "short interest ratio" (SIR)
Exponent's "short interest ratio" (SIR) is the quantity of Exponent shares currently shorted divided by the average quantity of Exponent shares traded daily (recently around 196642.58555133). Exponent's SIR currently stands at 5.26. In other words for every 100,000 Exponent shares traded daily on the market, roughly 5260 shares are currently held short.
However Exponent's short interest can also be evaluated against the total number of Exponent shares, or, against the total number of tradable Exponent shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Exponent's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Exponent shares in existence, roughly 20 shares are currently held short) or 0.0201% of the tradable shares (for every 100,000 tradable Exponent shares, roughly 20 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Exponent.
Find out more about how you can short Exponent stock.
Exponent share dividends
Dividend payout ratio: 46.71% of net profits
Recently Exponent has paid out, on average, around 46.71% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.81% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Exponent shareholders could enjoy a 0.81% return on their shares, in the form of dividend payments. In Exponent's case, that would currently equate to about $0.77 per share.
While Exponent's payout ratio might seem fairly standard, it's worth remembering that Exponent may be investing much of the rest of its net profits in future growth.
Exponent's most recent dividend payout was on 24 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 June 2021 (the "ex-dividend date").
Have Exponent's shares ever split?
Exponent's shares were split on a 2:1 basis on 7 June 2018. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Exponent shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Exponent shares which in turn could have impacted Exponent's share price.
Exponent share price volatility
Over the last 12 months, Exponent's shares have ranged in value from as little as $67.9693 up to $102.1891. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Exponent's is 0.3139. This would suggest that Exponent's shares are less volatile than average (for this exchange).
Exponent, Inc. , together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government.
Stocks similar to Exponent
Exponent in the news
Exponent, Inc. (EXPO) CEO Dr. Catherine Corrigan on Q2 2021 Results - Earnings Call Transcript
Exponent Inc (EXPO) Q2 2021 Earnings Call Transcript
Exponent (EXPO) Q2 Earnings and Revenues Surpass Estimates
Frequently asked questionsWhat percentage of Exponent is owned by insiders or institutions?
Currently 1.195% of Exponent shares are held by insiders and 92.468% by institutions. How many people work for Exponent?
Latest data suggests 906 work at Exponent. When does the fiscal year end for Exponent?
Exponent's fiscal year ends in January. Where is Exponent based?
Exponent's address is: 149 Commonwealth Drive, Menlo Park, CA, United States, 94025 What is Exponent's ISIN number?
Exponent's international securities identification number is: US30214U1025 What is Exponent's CUSIP number?
Exponent's Committee on Uniform Securities Identification Procedures number is: 30214U102
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert